NIH-funded research R01 grant

Preventing and treating fatty liver during pregnancy and after childbirth

Official title: Targeting Nonalcoholic Fatty Liver Disease during the reproductive period to improve women's health outcomes

Funded at Weill Medical Coll of Cornell Univ · NIH-11228037 · Data updated 2026-11-12

This project screens pregnant and postpartum women for fatty liver using blood tests and non-invasive tools to track liver changes that could affect their long-term health.

More Fatty Liver research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 15, 2024
Project endJune 30, 2029
Funding year2025
Award (this year)$679,731
NIH project number7R01DK139189-02
Project IDNIH-11228037 on NIH RePORTER

Who could benefit from this research

Could help

Pregnant people or women of reproductive age (especially those with higher pre-pregnancy weight or who identify as Hispanic) are the best fit for this work.

Less likely to help

People who are not pregnant, men, or those with liver disease from other known causes are unlikely to benefit from this pregnancy-focused effort.

What this research studies

If you join, you'll be offered screening during pregnancy using non-invasive tests and blood-based lipid analysis to look for signs of MASLD/MASH. The team will collect clinical information, blood samples, and follow you after delivery to see whether liver disease appears or gets worse. Researchers aim to identify people at higher risk—for example, those with higher pre-pregnancy weight or Hispanic ethnicity—to enable earlier monitoring and care. Participation typically involves questionnaires, blood draws, and clinic visits before and after childbirth.

Why it matters

Potential benefit: If successful, this work could lead to earlier detection and targeted follow-up to help prevent advanced liver disease in women.

How similar studies have gone: A prior pilot (FLIP I) found a 14% prevalence of MASLD in pregnancy and worsening after delivery, so the approach is promising but still being expanded and tested.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Kushner, Tatyana — Weill Medical Coll of Cornell Univ
  • Study coordinator: Kushner, Tatyana

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.